Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1997 3
1998 3
1999 2
2000 1
2001 3
2002 3
2003 2
2005 3
2006 4
2007 4
2008 4
2009 2
2010 4
2011 3
2012 1
2013 6
2014 7
2015 2
2016 1
2017 1
2018 1
2020 2
2021 1
2022 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic modulation of prostate cancer metastasis.
Krishna SN, Bergan RC. Krishna SN, et al. Among authors: bergan rc. Future Med Chem. 2014 Feb;6(2):223-39. doi: 10.4155/fmc.13.201. Future Med Chem. 2014. PMID: 24467245 Review.
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter.
Trinh JQ, Ellithi M, Shonka N, Bergan RC. Trinh JQ, et al. Among authors: bergan rc. Clin Cancer Res. 2023 Feb 1;29(3):684. doi: 10.1158/1078-0432.CCR-22-2968. Clin Cancer Res. 2023. PMID: 36722140 No abstract available.
Inhibition of cancer cell invasion and metastasis by genistein.
Pavese JM, Farmer RL, Bergan RC. Pavese JM, et al. Among authors: bergan rc. Cancer Metastasis Rev. 2010 Sep;29(3):465-82. doi: 10.1007/s10555-010-9238-z. Cancer Metastasis Rev. 2010. PMID: 20730632 Free PMC article. Review.
Endoglin suppresses human prostate cancer metastasis.
Lakshman M, Huang X, Ananthanarayanan V, Jovanovic B, Liu Y, Craft CS, Romero D, Vary CP, Bergan RC. Lakshman M, et al. Among authors: bergan rc. Clin Exp Metastasis. 2011 Jan;28(1):39-53. doi: 10.1007/s10585-010-9356-6. Epub 2010 Oct 28. Clin Exp Metastasis. 2011. PMID: 20981476 Free PMC article.
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.
Li A, Keck JM, Parmar S, Patterson J, Labrie M, Creason AL, Johnson BE, Downey M, Thomas G, Beadling C, Heiser LM, Kolodzie A, Guimaraes AR, Corless CL, Gray JW, Mills GB, Bergan RC, Mitri ZI. Li A, et al. Among authors: bergan rc. NPJ Precis Oncol. 2021 Mar 26;5(1):28. doi: 10.1038/s41698-021-00165-4. NPJ Precis Oncol. 2021. PMID: 33772089 Free PMC article.
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.
Graff JN, Alumkal JJ, Drake CG, Thomas GV, Redmond WL, Farhad M, Cetnar JP, Ey FS, Bergan RC, Slottke R, Beer TM. Graff JN, et al. Among authors: bergan rc. Oncotarget. 2016 Aug 16;7(33):52810-52817. doi: 10.18632/oncotarget.10547. Oncotarget. 2016. PMID: 27429197 Free PMC article. Clinical Trial.
65 results